News
2h
Dealbreaker on MSNEli Lilly Pays $1 Billion For Non-Opioid Pain Med MakerEli Lilly’s acquisition of SiteOne Therapeutics comes ahead of Phase 2 testing of the startup’s lead drug candidate, which ...
Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...
The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...
The U.S. imports more pharmaceutical products from Ireland than from any other country -- nearly $50 billion last year. It won't be surprising if the Trump administration especially targets those ...
President Trump signed a major executive order (EO), telling drug manufacturers to either lower the cost of prescription ...
President Trump claimed his “most favored nation” executive order could cause U.S. drug prices to “drop like a rock” in a ...
Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...
President Trump on Thursday claimed his recent “most favored nation” executive order could cause U.S. drug prices to “drop like a rock” in just a matter of weeks, saying ...
U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...
Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results